The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.
Top 5 Upgrades:
Raymond James upgraded AMD (AMD) to Strong Buy from Outperform with a price target of $641, up from $565. The firm believes AMD offers the "strongest combination of direct earnings leverage" given its data center positioning and market share gains.
Wolfe Research upgraded Moderna (MRNA) to Peer Perform from Underperform without a price target. The firm says the positive melanoma trial de-risks the intismeran platform.
Wells Fargo upgraded Shift4 Payments (FOUR) to Overweight from Equal Weight with a price target of $59, up from $55. The firm sees an improved share setup post the Q2 report.
Morgan Stanley upgraded Dynatrace (DT) to Overweight from Equal Weight with a price target of $65, up from $58. The firm says the observability market is experiencing the healthiest demand since 2022 amid the strongest public cloud growth in several years.
#upgraded #target #market #equal
Top 5 Upgrades:
Raymond James upgraded AMD (AMD) to Strong Buy from Outperform with a price target of $641, up from $565. The firm believes AMD offers the "strongest combination of direct earnings leverage" given its data center positioning and market share gains.
Wolfe Research upgraded Moderna (MRNA) to Peer Perform from Underperform without a price target. The firm says the positive melanoma trial de-risks the intismeran platform.
Wells Fargo upgraded Shift4 Payments (FOUR) to Overweight from Equal Weight with a price target of $59, up from $55. The firm sees an improved share setup post the Q2 report.
Morgan Stanley upgraded Dynatrace (DT) to Overweight from Equal Weight with a price target of $65, up from $58. The firm says the observability market is experiencing the healthiest demand since 2022 amid the strongest public cloud growth in several years.
#upgraded #target #market #equal
2 months ago
